Impact of European Medicines Agency (EMA) Clinical Trial Transparency Policies on Health Technology Assessment (HTA) Decisions In the UK
May 1, 2018, 00:00
10.1016/j.jval.2018.04.793
https://www.valueinhealthjournal.com/article/S1098-3015(18)31093-3/fulltext
Title :
Impact of European Medicines Agency (EMA) Clinical Trial Transparency Policies on Health Technology Assessment (HTA) Decisions In the UK
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(18)31093-3&doi=10.1016/j.jval.2018.04.793
First page :
Section Title :
Open access? :
No
Section Order :
108